A carregar...

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injections of the missing FVIII often lead to the formation of inhibitory antibodies. Patients who develop high levels of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yatuv, Rivka, Robinson, Micah, Dayan-Tarshish, Inbal, Baru, Moshe
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2939703/
https://ncbi.nlm.nih.gov/pubmed/20856833
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!